Literature DB >> 8825054

Clinical features of cystic fibrosis patients with rare genotypes.

G Castaldo1, E Rippa, V Raia, D Salvatore, C Massa, G de Ritis, F Salvatore.   

Abstract

We describe the clinical features of seven cystic fibrosis patients from southern Italy who bear rare genotypes: (1) a patient homozygous for the 2183 AA-->G mutation who was affected by a very early pulmonary form of cystic fibrosis, and five patients who were compound heterozygotes either for the 2183 AA-->G mutation or for the I148T mutation, in both instances with the delta F508 mutation; and (2) a patient homozygous for the early nonsense R553X mutation who showed only a moderately severe form of cystic fibrosis. Our results confirm that environmental or genetic factors unrelated to the CF disease contribute significantly to the development of the phenotype.

Entities:  

Mesh:

Year:  1996        PMID: 8825054      PMCID: PMC1051817          DOI: 10.1136/jmg.33.1.73

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  15 in total

1.  Mild pulmonary disease in a cystic fibrosis child homozygous for R553X.

Authors:  J Cheadle; L al-Jader; M Goodchild; A L Meredith
Journal:  J Med Genet       Date:  1992-08       Impact factor: 6.318

2.  The relation between genotype and phenotype in cystic fibrosis--analysis of the most common mutation (delta F508).

Authors:  E Kerem; M Corey; B S Kerem; J Rommens; D Markiewicz; H Levison; L C Tsui; P Durie
Journal:  N Engl J Med       Date:  1990-11-29       Impact factor: 91.245

3.  A cystic fibrosis patient homozygous for the nonsense mutation R553X.

Authors:  J Bal; M Stuhrmann; M Schloesser; J Schmidtke; J Reiss
Journal:  J Med Genet       Date:  1991-10       Impact factor: 6.318

4.  Discrimination between recurrent mutation and identity by descent: application to point mutations in exon 11 of the cystic fibrosis (CFTR) gene.

Authors:  J Reiss; D N Cooper; J Bal; R Slomski; G R Cutting; M Krawczak
Journal:  Hum Genet       Date:  1991-08       Impact factor: 4.132

5.  Analysis of the complete coding region of the CFTR gene in a cohort of CF patients from north-eastern Italy: identification of 90% of the mutations.

Authors:  A Bonizzato; L Bisceglia; C Marigo; E Nicolis; C Bombieri; C Castellani; G Borgo; L Zelante; G Mastella; G Cabrini
Journal:  Hum Genet       Date:  1995-04       Impact factor: 4.132

6.  Severe deficiency of cystic fibrosis transmembrane conductance regulator messenger RNA carrying nonsense mutations R553X and W1316X in respiratory epithelial cells of patients with cystic fibrosis.

Authors:  A Hamosh; B C Trapnell; P L Zeitlin; C Montrose-Rafizadeh; B J Rosenstein; R G Crystal; G R Cutting
Journal:  J Clin Invest       Date:  1991-12       Impact factor: 14.808

7.  Prenatal diagnosis of cystic fibrosis by DNA amplification for detection of KM-19 polymorphism.

Authors:  G L Feldman; R Williamson; A L Beaudet; W E O'Brien
Journal:  Lancet       Date:  1988-07-09       Impact factor: 79.321

8.  CA/GT microsatellite alleles within the cystic fibrosis transmembrane conductance regulator (CFTR) gene are not generated by unequal crossingover.

Authors:  N Morral; V Nunes; T Casals; X Estivill
Journal:  Genomics       Date:  1991-07       Impact factor: 5.736

9.  Genetic determination of exocrine pancreatic function in cystic fibrosis.

Authors:  P Kristidis; D Bozon; M Corey; D Markiewicz; J Rommens; L C Tsui; P Durie
Journal:  Am J Hum Genet       Date:  1992-06       Impact factor: 11.025

10.  Lung involvement, the delta F508 mutation and DNA haplotype analysis in cystic fibrosis.

Authors:  F Santamaria; D Salvatore; O Castiglione; V Raia; G de Ritis; G Sebastio
Journal:  Hum Genet       Date:  1992-03       Impact factor: 4.132

View more
  1 in total

1.  Molecular epidemiology of cystic fibrosis mutations and haplotypes in southern Italy evaluated with an improved semiautomated robotic procedure.

Authors:  G Castaldo; E Rippa; G Sebastio; V Raia; P Ercolini; G de Ritis; D Salvatore; F Salvatore
Journal:  J Med Genet       Date:  1996-06       Impact factor: 6.318

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.